PKN2
Serine/threonine-protein kinase N2
Also known as: Pak-2, PKN2_HUMAN, PRK2, PRKCL2, STK7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16513
- Gene
- PKN2
- Ensembl
- ENSG00000065243
- Chromosome
- 1
- Canonical length
- 984 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol
OverviewNCBI Gene
Enables RNA polymerase binding activity; histone deacetylase binding activity; and protein serine/threonine kinase activity. Involved in several processes, including apical junction assembly; positive regulation of cell cycle; and positive regulation of viral genome replication. Located in several cellular components, including cleavage furrow; cytoskeleton; and midbody. Part of protein-containing complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
984 residues, UniProt reviewed canonical sequence.
>Q16513|PKN2
1 MASNPERGEI LLTELQGDSR SLPFSENVSA VQKLDFSDTM VQQKLDDIKD RIKREIRKEL
61 KIKEGAENLR KVTTDKKSLA YVDNILKKSN KKLEELHHKL QELNAHIVVS DPEDITDCPR
121 TPDTPNNDPR CSTSNNRLKA LQKQLDIELK VKQGAENMIQ MYSNGSSKDR KLHGTAQQLL
181 QDSKTKIEVI RMQILQAVQT NELAFDNAKP VISPLELRME ELRHHFRIEF AVAEGAKNVM
241 KLLGSGKVTD RKALSEAQAR FNESSQKLDL LKYSLEQRLN EVPKNHPKSR IIIEELSLVA
301 ASPTLSPRQS MISTQNQYST LSKPAALTGT LEVRLMGCQD ILENVPGRSK ATSVALPGWS
361 PSETRSSFMS RTSKSKSGSS RNLLKTDDLS NDVCAVLKLD NTVVGQTSWK PISNQSWDQK
421 FTLELDRSRE LEISVYWRDW RSLCAVKFLR LEDFLDNQRH GMCLYLEPQG TLFAEVTFFN
481 PVIERRPKLQ RQKKIFSKQQ GKTFLRAPQM NINIATWGRL VRRAIPTVNH SGTFSPQAPV
541 PTTVPVVDVR IPQLAPPASD STVTKLDFDL EPEPPPAPPR ASSLGEIDES SELRVLDIPG
601 QDSETVFDIQ NDRNSILPKS QSEYKPDTPQ SGLEYSGIQE LEDRRSQQRF QFNLQDFRCC
661 AVLGRGHFGK VLLAEYKNTN EMFAIKALKK GDIVARDEVD SLMCEKRIFE TVNSVRHPFL
721 VNLFACFQTK EHVCFVMEYA AGGDLMMHIH TDVFSEPRAV FYAACVVLGL QYLHEHKIVY
781 RDLKLDNLLL DTEGFVKIAD FGLCKEGMGY GDRTSTFCGT PEFLAPEVLT ETSYTRAVDW
841 WGLGVLIYEM LVGESPFPGD DEEEVFDSIV NDEVRYPRFL STEAISIMRR LLRRNPERRL
901 GASEKDAEDV KKHPFFRLID WSALMDKKVK PPFIPTIRGR EDVSNFDDEF TSEAPILTPP
961 REPRILSEEE QEMFRDFDYI ADWCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PKN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 46 nTPM
- small intestine: 29 nTPM
- duodenum: 29 nTPM
- rectum: 28 nTPM
- retina: 25 nTPM
- ovary: 24 nTPM
Single-cell type
- neutrophils: 828 nCPM
- microglia: 585 nCPM
- esophageal apical cells: 554 nCPM
- neutrophil progenitors: 443 nCPM
- urothelial cells: 373 nCPM
- adrenal cortex cells: 344 nCPM
Immune cell
- neutrophil: 81 nTPM
- eosinophil: 17 nTPM
- basophil: 15 nTPM
- classical monocyte: 9.9 nTPM
- naive B-cell: 9.3 nTPM
- plasmacytoid DC: 8.6 nTPM
Brain region
- cerebellum: 64 nTPM
- choroid plexus: 57 nTPM
- white matter: 57 nTPM
- basal ganglia: 50 nTPM
- pons: 48 nTPM
- medulla oblongata: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.15
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.97
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apical junction assembly
- apoptotic process
- cell adhesion
- cell division
- cell projection organization
- epithelial cell migration
- intracellular signal transduction
- positive regulation of cytokinesis
- positive regulation of mitotic cell cycle
- positive regulation of viral genome replication
- protein phosphorylation
- regulation of cell motility
- signal transduction
- vascular endothelial cell response to laminar fluid shear stress
Molecular functions
- ATP binding
- cadherin binding
- diacylglycerol-dependent serine/threonine kinase activity
- histone deacetylase binding
- kinase activity
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein tyrosine kinase activity
- RNA binding
- RNA polymerase binding
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Protein kinase domain
- AGC-kinase, C-terminal
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- HR1 rho-binding domain
- Protein kinase, ATP binding site
- Protein kinase, C-terminal
- C2 domain superfamily
- HR1 repeat superfamily
- Serine/threonine-protein kinase N, first HR1 domain
- Serine/threonine-protein kinase N, C2 domain
- Protein kinase domain
- Protein kinase C terminal domain
- Hr1 repeat
KeywordsUniProt
- Acetylation
- Apoptosis
- ATP-binding
- Cell adhesion
- Cell cycle
- Cell division
- Cell junction
- Cell projection
- Cilium biogenesis/degradation
- Coiled coil
- Cytoplasm
- Cytoskeleton
- Host-virus interaction
- Kinase
- Membrane
- Nucleotide-binding
- Nucleus
- Phosphoprotein
- Repeat
- Serine/threonine-protein kinase
- Transcription
- Transcription regulation
- Transferase
InteractionsUniProt · HPA
Protein binding partners of PKN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PKN2 as an antibody target. Whether an autoantibody or antibody against PKN2 could matter depends on whether native PKN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PKN2 is annotated at the cell surface, where native PKN2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PKN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...